Radek Ptacek

Radek Ptacek

Auto-generated profile, based on publicly available information

Radek Ptacek

Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

55Years (1972-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2014 in Medical Science Monitor Basic Research
Verified
Journal Article
Open access
PDF file
KMKirk J. Mantione
Kirk J. Mantione
RKRichard M. Kream
Richard M. Kream
HKHana Kuzelova
Hana Kuzelova
RPRadek Ptacek
Radek Ptacek
JRJiri Raboch
Jiri Raboch
George B. StefanoGeorge B. Stefano
George B. Stefano
Understanding the control of gene expression is critical for our understanding of the relationship between genotype and phenotype. The need for reliable assessment of transcript abundance in biological samples has driven scientists to develo...

1 January 2011 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
RPRadek Ptacek
Radek Ptacek
HKHana Kuzelova
Hana Kuzelova
George B. StefanoGeorge B. Stefano
George B. Stefano
Dopamine receptors control neural signals that modulates behavior. Dopamine plays an important role in normal attention; that is the reason for studying the genes of the dopaminergic system, mainly in connection with disorders of attention. DRD4 influences the postsynaptic action of dopamine and is implicated in many neurological processes, exhibits polymorphism and is one of the most studied genes in connection with psychiatric disorders. Associations were found with ADHD (attention deficit hyperactivity disorder), substance dependences, several specific personality traits, and reaction to stress. These findings have implications for pharmacogenetics. This article reviews the principle published associations of DRD4 variants with psychiatric disorders.

26 May 2019 in Medical Science Monitor
Verified
Journal Article
Closed access
PDF file
RPRadek Ptacek
Radek Ptacek
SWSimon Weissenberger
Simon Weissenberger
EBEllen Braaten
Ellen Braaten
MKMartina Klicperova-Baker
Martina Klicperova-Baker
MGMichal Goetz
Michal Goetz
George B. StefanoGeorge B. Stefano
George B. Stefano
Attention deficit hyperactivity disorder (ADHD) is a lifelong neurodevelopmental disorder that can affect many areas of the daily life of individuals and is associated with poor health outcomes and with debilitating deficits in executive fun...

1 January 2014 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
RKRichard M. Kream
Richard M. Kream
RPRadek Ptacek
Radek Ptacek
HKHana Kuzelova
Hana Kuzelova
George B. StefanoGeorge B. Stefano
George B. Stefano
JRJiří Raboch
Jiří Raboch
MGMichal Goetz
Michal Goetz
Background:Attention deficit hyperactivity disorder (ADHD) is a neurological/behavioral disorder characterized by inattention or hyperactivity and impulsivity, or combined symptomatology. Children with ADHD are predisposed to irregular and/or impulsi...


11 August 2011 in Chronobiology International
Verified
Journal Article
Closed access
PDF file
MNMarta Nováková
Marta Nováková
IPIvo Paclt
Ivo Paclt
RPRadek Ptáček
Radek Ptáček
HKHana Kuželová
Hana Kuželová
IHIvan Hájek
Ivan Hájek
ASAlena Sumová
Alena Sumová
Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood. Problems with sleep structure, efficiency, and timing have been reported in some, but not all, studies on ADHD children. As the sleep-wake cycle belongs to circadian rhythms, the timekeeping circadian system might be involved in ADHD. To assess whether the circadian system of ADHD children differs from that of controls, the rhythm of the pineal hormone melatonin was used as a reliable marker of the system. Saliva from 34 ADHD and 43 control 6- to 12-yr-old children was sampled at 2-h intervals throughout the entire 24-h cycle, and the melatonin profiles of the ADHD and control children were compared. The nocturnal melatonin peaks of the ADHD and control group did not differ significantly. The high nocturnal interindividual variability of the peaks seen in adulthood was present already in the studied children. The 24-h melatonin profiles of all the ADHD subjects did not differ significantly from those of the control subjects. Categorization of subjects according to age, into groups of 6- to 7-yr-old (9 ADHD, 5 control), 8- to 9-yr-old (16 ADHD, 26 control), and 10- to 12-yr-old (9 ADHD, 12 control) children, revealed significant differences between the ADHD and control group in the melatonin rhythm waveform, but not in nocturnal melatonin peaks; the peaks were about the same in both groups and did not change significantly with increasing age. In the oldest, but not in the younger, children, the melatonin signal duration in the ADHD group was shorter than in the control group. The difference might be due to the fact that whereas in the control group both the evening melatonin onset and the morning offset phase delayed in the oldest children relative to those in the youngest children, in the ADHD group only the onset, but not the offset, phase delayed with increasing age. The data may indicate subtle differences between the circadian system of ADHD and control children during development. (Author correspondence: sumova@biomed. cas. cz )